Psychiatry · Chanhassen, MN
NPI
1194707828
Since 2005
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
7945 Stone Creek Dr, Ste 130
Chanhassen, MN, 55317
Phone (952) 241-4050
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
554 services
Medicare patients, 2024
118
Average age 63
Drug cost, 2024
$1.3M
5,277 prescriptions
Company payments, 2025
$17K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas C Winegarden was code 99214 (office e&m - established), 454 times for 111 patients. In total Thomas C Winegarden billed 554 services in 7 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 454 | 111 | $81.87 | $37K |
| 99213 Office E&M - Established | Office | 61 | 47 | $61.39 | $3,745 |
| 90833 Psychotherapy - Nongroup | Office | 19 | 15 | $54.44 | $1,034 |
| 99205 Office E&M - New | Office | 13 | 13 | $148.53 | $1,931 |
By year: 2022 $41K for 564 services; 2023 $53K for 676 services; 2024 $44K for 554 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas C Winegarden prescribed most often to Medicare patients was Quetiapine Fumarate, with 451 prescriptions and refills. In total Thomas C Winegarden wrote 5,277 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 451 | 780 | 72 | $15K |
| Mirtazapine Generic | 416 | 751 | 77 | $5,845 |
| Clozapine Generic | 293 | 294 | 22 | $24K |
| Trintellix Vortioxetine Hydrobromide | 293 | 451 | 47 | $213K |
| Eszopiclone Generic | 229 | 271 | 39 | $6,905 |
| Lamotrigine Generic | 217 | 340 | 38 | $3,098 |
| Trazodone Hcl Generic | 198 | 342 | 35 | $2,556 |
| Gabapentin Generic | 175 | 208 | 26 | $2,657 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 150 | 150 | 25 | $5,663 |
| Vilazodone Hcl Generic | 146 | 204 | 22 | $16K |
| Bupropion Xl Bupropion Hcl | 133 | 241 | 25 | $2,839 |
| Atomoxetine Hcl Generic | 117 | 147 | 20 | $7,971 |
| Olanzapine Generic | 109 | 158 | 14 | $4,281 |
| Quetiapine Fumarate Er Quetiapine Fumarate | 104 | 185 | 18 | $4,676 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 98 | 176 | 15 | $1,726 |
Brand drugs: 638 claims; generic drugs: 4,639 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas C Winegarden $17K ($17K in general payments such as food, travel and fees) from 11 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $16K.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 21 | $16K |
| Neuronetics, Inc. STIM | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $37.02 |
| Supernus Pharmaceuticals, Inc. SUPN | 2 | $33.18 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $28.35 |
| Lundbeck LLC | 1 | $17.54 |
| Lilly USA, LLC LLY | 1 | $15.56 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $14.73 |
| Novo Nordisk Inc NVO | 1 | $14.62 |
| Collegium Pharmaceutical, Inc. COLL | 1 | $14.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.